COVID-19

September 8, 2022

PheWAS reveals post-COVID-19 diagnoses

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

By Bill Snyder
August 25, 2022

Neurologic complications common in children hospitalized with COVID

Vanderbilt researchers have found another reason to vaccinate children against COVID-19: to help reduce the likelihood of neurologic complications caused by the virus.

By Jessica Pasley
Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.
August 24, 2022

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

By Bill Snyder
August 24, 2022

Reminder: COVID-19 infection prevention guidelines for all VUMC workforce members

August 11, 2022

A story of family and faith: Jennifer received a kidney transplant. The donor was Capri, who is married to Dennis. Jennifer is Dennis’ ex-wife. It’s complicated.

The extended family has grown closer as a result of Capri’s generosity. She says her faith led her to the decision.

By Matt Batcheldor
August 10, 2022

NAM special publication focuses on COVID lessons learned

A new special publication from the National Academy of Medicine spotlights the opportunity to leverage lessons learned from the pandemic to transform health, health care and health delivery in the United States.

By Craig Boerner
July 28, 2022

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
By Bill Snyder
July 20, 2022

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
By Leigh MacMillan
July 7, 2022

Convalescent plasma doesn’t help severely ill COVID patients: study

A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover
By Nancy Humphrey
July 6, 2022

Study shows two vaccine doses for mothers eases COVID complications for infants

Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.
By Jessica Pasley
June 27, 2022

Occupational Health offers tips to kick off summer on a healthy note

We are officially into summer, which means vacations are ramping up. As you write your checklist, pack your suitcase, and book your trip, here are few important reminders.
By Wayne Wood
June 22, 2022

COVID-19 vaccines for children 6 months through 4 years available

Children ages 6 months through age 4 years are now eligible to get the COVID-19 vaccine. Monroe Carell Jr. Children’s Hospital at Vanderbilt will offer vaccines for this age group on Wednesday, Thursday, and Friday, June 22, 23 and 24. Appointments are required and available between 2 p.m. and 5:30 p.m.   Saturday, June 25. Appointments are required and available between 8 a.m. and 11:30 a.m.
By VUMC News and Communications
June 15, 2022

Dolly Parton donates $1 million to pediatric infectious disease research at Vanderbilt University Medical Center

Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center to help in the fight against serious infectious diseases such as coronavirus that have worldwide ramifications.
By Craig Boerner